Institutional investors purchased a net $202.5 thousand shares of MNOV during the quarter ended September 2014. This may signal that the smart money is gaining interest in this company as the 5.01% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLACKROCK FUND ADVISORS Bought 70.0 Thousand shares of MediciNova Inc
RENAISSANCE TECHNOLOGIES LLC Bought 49.4 Thousand shares of MediciNova Inc